Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22885407 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift
Condition: Temporary Auditory Threshold Shift
Interventions: Drug: SPI-1005 Low dose;   Drug: SPI-1005 Middle dose;   Drug: SPI-1005 High dose;   Drug: Placebo

Indicates status has not been verified in more than two years